4
Changes in Ownership
ProMIS Neurosciences Inc. Filed Acc 0001104659-24-121133
Options or other derivatives
- Chief Scientific Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cashman Neil · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-18 | Grant or award : show line 1 in the form Option (right to buy) | +200,000 | 200,000 | D |
Loading xslF345X05/tm2429073-2_4seq1.xml…